Sanofi vets Takeda, devicemaker CEO candidates; Shaq returns for IcyHot; Royalty Pharma buys royalties on Vertex's Kalydeco.
The company refutes a Financial Times rumor that one was happening soonish.
The $14.2-billion deal is expected to close in the second half of this year.
J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC products.
Novo's global diabetes study finds that only 29% of polled patients were asked what they thought about prescribed regimens.
Lawrence Foster's crisis management strategy has become the touchstone for reputation management. His advice is credited with saving Tylenol from being wiped from the marketplace, despite a deadly tampering crisis.
The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.
Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.
Two studies released show that the story behind lower consumer healthspend isn't about generics improving health.
The CEO's unexpected departure is part of the health information brand's latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.
The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.
The first drug for morning sickness in thirty years enters the market this month.
Health-seeking consumers continue social-media push; Scioderm scores FDA's "Breakthrough" designation for bullosa agent; and GSK files NDA for airway treatment.
Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer.
IndyCar's first licensed driver heads up a diabetes awareness campaign that focuses on community—both online and in real life.
CEO Alex Gorsky said OTC brands are coming back. Meanwhile, pharmaceutical sales provided ballast to the year's numbers.
Bayer HealthCare inked a deal to swallow vitamin and supplement company Schiff Nutrition International, in a transaction valued at about $1.2 billion.
Harte-Hanks, the direct marketing giant, is looking to break off a piece of the burgeoning health and wellness market with the launch of True Health + Wellness.
WebMD executed a cross-platform magazine redesign with a more visual and celeb-centric new look.
The drugmaker is paying $250 million to Nexium marketer AstraZeneca for the rights to sell an OTC version, in a deal that may signal a deepening relationship between the two firms.
Around a third of US adults use social media as a health resource, according to a survey by PricewaterhouseCoopers - whether seeking out medical info, sharing symptoms and experiences or rating drugs, devices, doctors, hospitals and health plans.
The drug industry gets a lot of grief over its online communications to consumers, but a study has found that sites posted by doctors and hospitals and touting surgeries are often dreadful—and far less tightly regulated.
A global study of consumer attitudes towards health found evidence for the "empowered consumer" hypothesis, with respondents expressing a greater sense of control over and responsibility for their health.
GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.
Don't tell the New York Post, but Pfizer is boosting bike lanes as part of an Advil promotion.
New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta?
Amazing Race host Phil Keoghan will lead a Novartis-sponsored team of women pro cyclists on a 10-city bike tour to raise awareness of MS.
Consumers continue to trust health magazines, websites and WebMD more than user-generated contribution sites like Wikipedia, Facebook or Twitter for medical information, according to a survey.
InVentiv's GSW is going after the consumer health and wellness market with an offshoot, dubbed The Well @GSW, aimed at OTC brands, consumer products and retail accounts.
Havas Drive has launched a practice focused on developing digital products for persons with disabilities and those undergoing rehabilitative therapies.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.